Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib versus placebo in rheumatoid arthritis with inadequate response to TNF inhibitors on background methotrexate
2009-014296-40Phase 3Completed
- Sponsor
- Pfizer
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tofacitinib in rheumatoid arthritis (RA) (3 arms), sponsored by Pfizer. Primary endpoint: ACR20 responder rate at Month 3. Started Aug 2009; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-014296-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014296-40.